000 | 01358 a2200385 4500 | ||
---|---|---|---|
005 | 20250512001026.0 | ||
264 | 0 | _c19860410 | |
008 | 198604s 0 0 eng d | ||
022 | _a0012-3692 | ||
024 | 7 |
_a10.1378/chest.89.3_supplement.123s _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKennedy, J I | |
245 | 0 | 0 |
_aReduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent. _h[electronic resource] |
260 |
_bChest _cMar 1986 |
||
300 |
_a123S-125S p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBleomycin _xtoxicity |
650 | 0 | 4 |
_aChelating Agents _xpharmacology |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 |
_aDeferoxamine _xpharmacology |
650 | 0 | 4 |
_aHydroxyproline _xanalysis |
650 | 0 | 4 |
_aIron _xphysiology |
650 | 0 | 4 |
_aLung _xanalysis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMesocricetus |
650 | 0 | 4 |
_aOxygen _xmetabolism |
650 | 0 | 4 |
_aPulmonary Fibrosis _xchemically induced |
650 | 0 | 4 | _aRats |
700 | 1 | _aChandler, D B | |
700 | 1 | _aJackson, R M | |
700 | 1 | _aFulmer, J D | |
773 | 0 |
_tChest _gvol. 89 _gno. 3 Suppl _gp. 123S-125S |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1378/chest.89.3_supplement.123s _zAvailable from publisher's website |
999 |
_c2425102 _d2425102 |